compound 13 lacked substantial dopaminergic activity as measured by its effects on dopamine turnover in whole brain or striatum and its affinity for alpha-adrenergic binding sites was significantly less than for 5-ht1 binding sites .
C0282151
dopaminergic
C0013030
dopamine